Sub menu

 
 

(Approval lapsed) Cisplatin 1mg/mL (100mg/100mL) concentrate for solution for infusion (Accord, UK)

Section 19A approved medicine
(Approval lapsed) Cisplatin 1mg/mL (100mg/100mL) concentrate for solution for infusion (Accord, UK)
Section 19A approval holder
Accord Healthcare Pty Ltd ABN 49 110 502 513​
Phone
1800 222 673
Approved until
Status
Expired
Medicines in short supply/unavailable
CISPLATIN ACCORD cisplatin 50 mg/50 mL concentrated injection vial - ARTG 286786
CISPLATIN ACCORD cisplatin 100 mg/100 mL concentrated injection vial - ARTG 286791
Indication(s)

Cisplatin may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:

  • Metastatic non-seminomatous germ cell carcinoma
  • Advanced stage, refractory ovarian carcinoma
  • Advanced stage, refractory bladder carcinoma
  • Refractory squamous cell carcinoma of the head and neck
Related medicines shortage notifications
https://apps.tga.gov.au/Prod/msi/Search/Details/cisplatin
Images
Picture of Cisplatin 1mg/mL (100mg/100mL) concentrate for solution for infusion - carton

Help us improve the Therapeutic Goods Administration site